Harvard Bioscience Overview
- Year Founded
-
1901
- Status
-
Public
- Employees
-
339
- Stock Symbol
-
HBIO
- Investments
-
20
- Share Price
-
$8.75
- (As of Friday Closing)
Harvard Bioscience General Information
Description
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Contact Information
Website
www.harvardbioscience.comCorporate Office
- 84 October Hill Road
- Suite 10
- Holliston, MA 01746
- United States
Corporate Office
- 84 October Hill Road
- Suite 10
- Holliston, MA 01746
- United States
Harvard Bioscience Stock Performance
As of 20-Nov-2026, Harvard Bioscience’s stock price is $8.75. Its current market cap is $40M with 4.57M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $8.75 | $8.68 | $4.00 - $10.20 | $40M | 4.57M | 21.7K | -$2.59 |
Harvard Bioscience Financials Summary
As of 30-Sep-2026, Harvard Bioscience has a trailing 12-month revenue of $89.4M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 73,757 | 65,783 | 133,153 | 268,328 |
| Revenue | 89,413 | 86,550 | 94,135 | 112,250 |
| EBITDA | (111) | (46,524) | (972) | 8,035 |
| Net Income | (11,804) | (56,700) | (12,405) | (3,415) |
| Total Assets | 75,299 | 80,071 | 126,644 | 137,366 |
| Total Debt | 44,291 | 44,277 | 44,495 | 42,773 |
Harvard Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Harvard Bioscience Comparisons
Industry
Financing
Details
Harvard Bioscience Competitors (37)
One of Harvard Bioscience’s 37 competitors is Bio-Rad Laboratories, a Corporation company based in Hercules, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bio-Rad Laboratories | Corporation | Hercules, CA | ||||
| BGI Genomics | Formerly VC-backed | Shenzhen, China | ||||
| 10x Genomics | Formerly VC-backed | Pleasanton, CA | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Meridian Bioscience | Private Equity-Backed | Cincinnati, OH |
Harvard Bioscience Patents
Harvard Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4741824-A1 | System and method for longitudinal analysis of an organoid | Pending | 07-Nov-2024 | ||
| US-20260124612-A1 | System and method for longitudinal anaysis of an organoid | Pending | 07-Nov-2024 | ||
| US-12593828-B2 | Animal activity rack system | Active | 14-Mar-2024 | ||
| US-20250287925-A1 | Animal activity rack system | Active | 14-Mar-2024 | ||
| US-D1042881-S1 | Slide holder | Active | 04-May-2022 |
Harvard Bioscience Signals
Harvard Bioscience Acquisitions (20)
Harvard Bioscience’s most recent deal was a Merger/Acquisition with Data Sciences International for . The deal was made on 31-Jan-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Data Sciences International | 31-Jan-2018 | Merger/Acquisition | Monitoring Equipment | ||
| HEKA Elektronik Dr. Schulze | 08-Jan-2015 | Merger/Acquisition | Diagnostic Equipment | ||
| Triangle BioSystems International | 01-Oct-2014 | Merger/Acquisition | Monitoring Equipment | ||
| AHN Biotechnologie | 03-Feb-2012 | Merger/Acquisition | Other Devices and Supplies | ||
| CMA Microdialysis | 01-Jul-2011 | Merger/Acquisition | Medical Supplies |
Harvard Bioscience ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
25.11 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 67
Rank
Percentile
Harvard Bioscience Exits (2)
Harvard Bioscience’s most recent exit was on 03-Feb-2012 from AHN Biotechnologie. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| AHN Biotechnologie | 03-Feb-2012 | Completed |
|
||
| Denville Scientific | 02-Sep-2009 | Merger/Acquisition | Completed |
Harvard Bioscience Affiliates
Subsidiaries (10)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Data Sciences International | Saint Paul, MN | 2009 | |
| KD Scientific | Holliston, MA | 2004 | |
| Union Biometrica | Holliston, MA | 1998 | |
| Warner Instruments | Holliston, MA | 1988 | |
| BTX | Holliston, MA | 1983 |
Harvard Bioscience FAQs
-
When was Harvard Bioscience founded?
Harvard Bioscience was founded in 1901.
-
Where is Harvard Bioscience headquartered?
Harvard Bioscience is headquartered in Holliston, MA.
-
What is the size of Harvard Bioscience?
Harvard Bioscience has 339 total employees.
-
What industry is Harvard Bioscience in?
Harvard Bioscience’s primary industry is Other Devices and Supplies.
-
Is Harvard Bioscience a private or public company?
Harvard Bioscience is a Public company.
-
What is Harvard Bioscience’s stock symbol?
The ticker symbol for Harvard Bioscience is HBIO.
-
What is the current stock price of Harvard Bioscience?
As of 20-Nov-2026 the stock price of Harvard Bioscience is $8.75.
-
What is the current market cap of Harvard Bioscience?
The current market capitalization of Harvard Bioscience is $40M.
-
What is Harvard Bioscience’s current revenue?
The trailing twelve month revenue for Harvard Bioscience is $89.4M.
-
Who are Harvard Bioscience’s competitors?
Bio-Rad Laboratories, BGI Genomics, 10x Genomics, Illumina, and Meridian Bioscience are some of the 37 competitors of Harvard Bioscience.
-
What is Harvard Bioscience’s annual earnings per share (EPS)?
Harvard Bioscience’s EPS for 12 months was -$2.59.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process